VANGL1 and colorectal carcinoma: In particular, we were interested in the evaluation of the expression levels of the products of VANGL1, EGFR, and SMAD4 based on literature data and on the relationships we observed between the expression of their respective encoding genes and the clinical/pathological characteristics of the study CRC patients.